Skip to main content
. 2020 Oct 19;10:545921. doi: 10.3389/fonc.2020.545921

TABLE 2.

Lymph-Node-Positive disease at cystectomy and PLND in each histologic type within the SEER from 2004 to 2015.

No. of Patients (%)a
Histologic type Overall, N = 14363 LN negative, N = 10302 LN positive, N = 4061 P
Transitional cell carcinoma 13078 9422 (72.0) 3656 (28.0) <0.001
Squamous cell carcinoma 598 435 (72.7) 163 (27.3)
Adenocarcinoma 215 144 (67.0) 71 (33.0)
Small cell carcinoma 169 109 (64.5) 60 (35.5)
Neuroendocrine carcinoma 53 35 (66.0) 18 (34.0)
Signet ring cell carcinoma 85 35 (41.2) 50 (58.8)
Pseudosarcomatous carcinoma 45 37 (82.2) 8 (17.8)
Other histology 120 85 (70.8) 35 (29.2)

LN, lymph node; PLDN, pelvic lymph node dissection.